Andrew L. Coveler - Publications, H-index & Citations

Back

Andrew L. Coveler

Fred Hutchinson Cancer Center

30H-index

300Paper Count

6.8KCitation Count

Published Papers 42

Publication Date

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial

Nature Medicine

IF50

2026-04-14

OAAI

Devalingam Mahalingam; Rachna T. Shroff; Benedito A. Carneiro; Yan Ji; Andrew L. Coveler; Andres Cervantes; Vaibhav Sahai; Anne Ploquin; Sandrine Hiret; Noelle K. LoConte; Ivor J. Percent; Charles D. Lopez; Simon Pernot; Petr Kavan; Mary Mulcahy; Ryan Carr; Francis J. Giles; Chris Seifarth; Andrey Ugolkov; Taylor Weiskittel; Gil Fine; Mark Jaros; Andrew P. Mazar; Tanios S. Bekaii-Saab

Save

Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001

Cancers

IF4.4

2026-02-04

OAAI

Elena Gabriela Chiorean; Sheela R. Damle; David B. Zhen; Martin Whittle; Ben George; Howard Hochster; Andrew L. Coveler; Andrew Hendifar; Tomislav Dragovich; Rachael A. Safyan; Gentry T. King; William P. Harris; Barbara Dion; Amy Stoll D’Astice; Arthur Lee; Shelley Thorsen; Sita Kugel; Adam Rosenthal; Sunil Hingorani

Save

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis

Nature Communications

IF15.7

2026-01-12

OAAI

John H. Strickler; Andrea Cercek; Salvatore Siena; Thierry André; Kimmie Ng; Eric Van Cutsem; Christina Wu; Andrew Scott Paulson; Joleen M. Hubbard; Andrew L. Coveler; Christos Fountzilas; Adel Kardosh; Pashtoon Murtaza Kasi; Heinz-Josef Lenz; Kristen Ciombor; Elena Elez; David L. Bajor; Chiara Cremolini; Federico Sanchez; Mina Nayeri; Wentao Feng; Mark Bieda; Tanios S. Bekaii-Saab

Save

Prospective pilot evaluation of dark borosilicate oral contrast media for the evaluation of the stomach and small bowel using CT

ABDOMINAL RADIOLOGY

IF2.2

2025-12-01

PREAI

Mileto, Achille; Inoue, Akitoshi; Mohammadinejad, Payam; Coveler, Andrew L.; Lee, Yong S.; Leng, Shuai; Johnson, Matthew P.; Sun, Yuxin; Thomas, John V.; Yeh, Benjamin M.; Bruining, David H.; Fletcher, Joel G.

Save

Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer

ESMO Open

IF8.3

2025-06-01

OAAI

D. Mahalingam; A. Saeed; S.F. Powell; M. Huerta; V. Sahai; A.L. Coveler; E.J. Davis; N. Steeghs; M. Mulcahy; A.G. Raufi; L. Cavalcante; A. Cervantes; J. Berlin; T. Weisskittel; A. Ugolkov; A.P. Mazar; W. Mikrut; S. Smith; F.J. Giles; B.A. Carneiro

Save

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

VACCINES

IF3.4

2025-01-24

OAAI

Gwin III, William R.; Salazar, Lupe G.; Dai, James Y.; Higgins, Doreen; Coveler, Andrew L.; Childs, Jennifer S.; Blancas, Rosie; Dang, Yushe; Reichow, Jessica; Slota, Meredith; Lu, Hailing; Disis, Mary L.

Save

A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

CLINICAL CANCER RESEARCH

IF10.2

2024-08-06

OAAI

Coveler, Andrew L.; Reilley, Matthew J.; Zalupski, Mark; Macarulla, Teresa; Fountzilas, Christos; Ponz-Sarvise, Mariano; Nagrial, Adnan; Uboha, Nataliya V.; Frentzas, Sophia; Overman, Michael; Noonan, Anne; Messersmith, Wells A.; Pavlakis, Nick; Mettu, Niharika B.; Bisha, Ina; Wang, Ying; Smith, Paul; Murtomaki, Elina; Bielska, Agata A.; Bragulat, Veronique; Cooper, Zachary A.; Kumar, Rakesh; Spigel, David R.

Save

Phase I study of autologous CD8+and CD4+transgenic T cells expressing high-affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) in patients with metastatic pancreatic, colorectal and non-small cell lung cancers with KRAS G12V mutations

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Chiorean, Elena Gabriela; Coveler, Andrew; Safyan, Rachael; Cohen, Stacey; Lee, Sylvia; Yeung, Cecilia; Redman, Mary; Schmitt, Thomas; Chapuis, Aude; Greenberg, Philip D.

Save

A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer

INVESTIGATIONAL NEW DRUGS

IF2.7

2024-03-05

PREAI

Ko, Andrew H.; Coveler, Andrew L.; Schlechter, Benjamin L.; Bekaii-Saab, Tanios; Wolpin, Brian M.; Clark, Jeffrey W.; Bockorny, Bruno; Bai, Li-Yuan; Lin, Yu-Chin; Chiang, Evelyn; Langecker, Peter; Lin, Shih-Yao

Save

Preliminary safety results from a phase I study of autologous transgenic T cells expressing high affinity mesothelin-specific T cell receptor (TCR) (FH-TCR TMSLN) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDA)

CANCER RESEARCH

IF16.6

2024-01-16

PREAI

Chiorean, Elena G.; Chapuis, Aude; Coveler, Andrew; Yeung, Cecilia; Gooley, Ted; Zhen, David B.; King, Gentry; Cohen, Stacey; Hannan, Lindsay; Safyan, Rachael; Germani, Anthony; Ra, Susan; Casserd, Jennifer; Schmitt, Tom; Greenberg, Philip

Save

NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-01

PREAI

Khan, Khurum; Mukherjee, Uma; Schlechter, Benjamin L.; Ciombor, Kristen K.; Skolariki, Aglaia; Coveler, Andrew L.; Graham, Janet S.; Peters, Mary Linton; Cohen, Stacey A.; Mettu, Niharika; Marijon, Helene; Cosgrove, David; McKissock, Fiona G.; Oelmann, Elisabeth; Bloss, Jeffrey D.; Blagden, Sarah P.; de Gramont, Aimery; Berlin, Jordan; Evans, T. R. Jeffry

Save

Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) plus bevacizumab vs FOLFIRI plus bevacizumab for the second-line treatment of patients with advanced/metastatic colorectal cancer (NuTide:323)

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-01

PREAI

Wilson, Richard H.; Ciombor, Kristen K.; Coveler, Andrew L.; Graham, Janet S.; Schlechter, Benjamin L.; George, Thomas J.; Elez, Elena; Evans, T. R. Jeffry; Berlin, Jordan; de Gramont, Aimery; McKissock, Fiona G.; Oelmann, Elisabeth; Bloss, Jeffrey D.; Martini, Giulia; Bennouna, Jaafar; Modest, Dominik P.; Taieb, Julien; Tabernero, Josep

Save

Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Strickler, J. H.; Cercek, A.; Ng, K.; Siena, S.; Andre, T.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J.; Coveler, A. L.; Fountzilas, C.; Kardosh, A.; Kasi, P. M.; Lenz, H. J.; Ciombor, K. K.; Elez Fernandez, M. E.; Stecher, M.; Cronin, P.; Bieda, M.; Bekaii-Saab, T.

Save

Prospective longitudinal tumor-informed ctDNA in resectable biliary tract cancers

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

King, G.; Cohen, S. A.; Chiorean, E. G.; Harris, W. P.; Yeung, R.; Park, J.; Zhen, D. B.; Coveler, A. L.; Diehl, A.; Safyan, R.; Jurdi, A.; Brdiges, C.

Save

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-06-29

OAAI

Coveler, Andrew L.; Smith, David C.; Phillips, Tycel; Curti, Brendan D.; Goel, Sanjay; Mehta, Amitkumar N.; Kuzel, Timothy M.; Markovic, Svetomir N.; Rixe, Olivier; Bajor, David L.; Gajewski, Thomas F.; Gutierrez, Martin; Lee, Hun Ju; Gopal, Ajay K.; Caimi, Paolo; Heath, Elisabeth, I; Thompson, John A.; Ansari, Sahar; Jacquemont, Celine; Topletz-Erickson, Ariel; Zhou, Peigen; Schmitt, Michael W.; Grilley-Olson, Juneko E.

Save

A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer

CLINICAL CANCER RESEARCH

IF10.2

2023-04-24

OAAI

Disis, Mary L.; Dang, Yushe; Coveler, Andrew L.; Childs, Jennifer S.; Higgins, Doreen M.; Liu, Ying; Zhou, Jing; Mackay, Sean; Salazar, Lupe G.

Save

Phase I trial of the safety and immunogenicity of a tri-antigen vaccine targeting HER2, IGFBP-2, and IGF-IR in patients with non-metastatic breast cancer

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Stanton, Sasha E.; Wisinski, Kari B.; Gwin, William R.; Coveler, Andrew; Liao, John B.; Burkard, Mark; Bailey, Howard; Kim, KyungMann; Havinghurst, Thomas; DeShong, Katina; Childs, Jennifer S.; Dimond, Eileen; Wojtowicz, Margaret; Heckman-Stoddard, Brandy M.; Cecil, Denise; Disis, Mary

Save

Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-01-05

207

OAAI

Strickler, J. H.; Satake, H.; George, T. J.; Yaeger, R.; Hollebecque, A.; Garrido-Laguna, I.; Schuler, M.; Burns, T. F.; Coveler, A. L.; Falchook, G. S.; Vincent, M.; Sunakawa, Y.; Dahan, L.; Bajor, D.; Rha, S. -Y.; Lemech, C.; Juric, D.; Rehn, M.; Ngarmchamnanrith, G.; Jafarinasabian, P.; Tran, Q.; Hong, D. S.

Save

Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Wu, C.; Strickler, J. H.; Cercek, A.; Siena, S.; Andre, T.; Ng, K.; Van Cutsem, E.; Paulson, A. S.; Hubbard, J.; Coveler, A.; Fountzilas, C.; Kardosh, A.; Kasi, P. M.; Lenz, H. J.; Ciombor, K. K.; Fernandez, M. E. Elez; Hsu, L. I.; Stecher, M.; Zhao, K.; Bekaii-Saab, T.

Save

Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Strickler, J. H.; Cercek, A.; Siena, S.; Andre, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J.; Coveler, A.; Fountzilas, C.; Kardosh, A.; Kasi, P. M.; Lenz, H. J.; Ciombor, K. K.; Fernandez, M. E. Elez; Bajor, D. L.; Stecher, M.; Feng, W.; Bekaii-Saab, T.

Save

Research Directions